Pyruvate Kinase Deficiency (Non-spherocytic haemolytic anaemia)
Learn what the condition is, how it may be detected early, how it is treated or managed, and which breeds or species are linked to it.
Learn what the condition is, how it may be detected early, how it is treated or managed, and which breeds or species are linked to it.
A concise guide to the condition’s pattern, detection, management and urgency.
This snapshot is a general guide, not a diagnosis or treatment plan. New, severe or worsening signs require veterinary assessment.
Pyruvate kinase deficiency is an inherited red-blood-cell disorder caused by insufficient activity of the enzyme pyruvate kinase. Red blood cells rely heavily on glycolysis for energy because they do not contain mitochondria. Without adequate pyruvate kinase, they cannot maintain normal cell function and survive for their expected lifespan.
The abnormal red cells are removed prematurely from circulation, producing chronic haemolytic anaemia. The anaemia is described as non-spherocytic because the red cells do not have the spherical appearance typical of many immune-mediated haemolytic anaemias. The bone marrow responds by producing replacement cells, so the anaemia is usually regenerative.
Affected dogs may have pale gums, reduced stamina, rapid breathing, a fast heart rate and weakness. The spleen and liver often enlarge because they are heavily involved in removing and processing damaged red blood cells. Jaundice can occur. Over time, the disease can cause progressive changes in the liver and bone marrow, including iron accumulation and fibrosis, which contribute to the poor long-term prognosis described in some breeds.
Inheritance is autosomal recessive in recognised canine forms. Clinically normal carriers have one copy of the variant and do not develop the disease.
Because disease severity differs between breeds, prognosis should be based on the specific form rather than one universal expectation. There is no routine curative therapy, so management centres on supporting the dog through anaemia and limiting complications.
The course varies between breeds, but the disorder is more than a simple low red-cell count.
It identifies clear dogs, carriers and genetically affected dogs before anaemia becomes severe. Because inheritance is autosomal recessive, two carriers can produce affected puppies even though both parents are completely healthy. These signs can indicate worsening anaemia. Carrier identification is central to prevention.
DNA testing is the most effective screening method in breeds with a validated pyruvate kinase deficiency mutation.
In dogs with unknown genetic status, routine blood work may reveal a regenerative anaemia before obvious clinical signs develop. Persistent anaemia with increased young red blood cells, especially in a predisposed breed, should prompt investigation. Blood smear examination, bilirubin and other haemolysis markers help characterise the process.
Immune-mediated haemolytic anaemia must be distinguished from pyruvate kinase deficiency because treatment is very different. Genetic testing or specialised enzyme assays can confirm the inherited metabolic defect. A negative DNA result only excludes the specific mutation included in that breed test.
Seek assessment if a dog develops pale or yellow gums, reduced exercise tolerance, rapid breathing or unexplained weakness.
When an affected dog is diagnosed, parents and littermates should be tested where possible. Screening mixed-breed dogs is guided by ancestry and clinical findings because there is no single universal test covering every potential pyruvate kinase variant.
DNA tests are available for several breed-specific mutations and can confirm affected status or identify carriers. Diagnosis combines a regenerative haemolytic anaemia with exclusion of immune-mediated causes and confirmation by genetic or enzyme testing. Ongoing haemolysis can gradually affect the liver, bone marrow and overall exercise tolerance, so long-term assessment needs to consider both the anaemia and its systemic consequences.
Pyruvate kinase activity cannot currently be replaced in canine red blood cells, so management focuses on the consequences of chronic haemolytic anaemia and progressive organ changes. Management is therefore supportive and focused on the consequences of chronic haemolytic anaemia. Dogs that compensate well may need monitoring for a period without intensive treatment, while severe anaemia can require blood transfusion.
Transfusion restores oxygen-carrying capacity temporarily but does not correct the enzyme defect, so newly produced red cells continue to have shortened survival. Repeated transfusions are reserved for clinically significant episodes because they carry their own risks and can contribute to iron loading.
Long-term monitoring includes red-cell count, body weight, exercise tolerance and liver function. Progressive iron accumulation and fibrosis in the liver or bone marrow can become major complications in some breed forms. There is no simple dietary change that prevents the inherited red-cell destruction, although overall nutrition should remain balanced.
Splenectomy has been considered in some haemolytic disorders, but it is not a universal cure for canine pyruvate kinase deficiency and should only be discussed in specialist circumstances. Experimental therapies such as gene-based approaches are not routine clinical care.
Long-term care focuses on trends rather than a single blood count. Worsening exercise intolerance, pale gums, rapid breathing, weight loss or jaundice should prompt reassessment, while periodic blood work and liver evaluation help identify progressive anaemia or iron-related organ damage before the dog becomes acutely unwell.
American Eskimo dog
Open dog breed description, care requirements and conditions
Basenji
Open dog breed description, care requirements and conditions
Beagle
Open dog breed description, care requirements and conditions
Cairn terrier
Open dog breed description, care requirements and conditions
Chihuahua
Open dog breed description, care requirements and conditions
Pug
Open dog breed description, care requirements and conditions
Dachshund
Open dog breed description, care requirements and conditions
Labrador retriever
Open dog breed description, care requirements and conditions
Miniature Poodle
Open dog breed description, care requirements and conditions
Miniature Schnauzer
Open dog breed description, care requirements and conditions
Schnauzer (miniature, standard)
Open dog breed description, care requirements and conditions
West Highland white terrier
Open dog breed description, care requirements and conditions